Welcome to the Next Generation of Optometry-Tech

Routine eyes exams can
now help to save lives

Join a growing community of forward-thinking optometrists who are supercharging their offering with AI-powered health assessments.

In partnership with

Topcon Healthcare Microsoft National Vision America's Best Contacts & Eyeglasses American Heart Association Optos NVIDIA
Topcon Healthcare Microsoft National Vision America's Best Contacts & Eyeglasses American Heart Association Optos NVIDIA

You'll gain access to the Discovery Center where you can learn more about Toku’s AI products and pricing

Now available

Coming soon

Toku’s AI models have been developed using over

retinal images linked to medical records.

We never store or use your data
to improve or train AI models.

Improve
Retention

89%

of BioAge customers
intend to return
again in 12 months

Why Optometrists Love BioAge

30

seconds

Results return within

Online Reports

Patients get instant access to their results, along with recommendations from the American Heart Association.

Backed by Science

Increased BioAge results are proven to correlate with increased cardiovascular and metabolic risk factors like hypertension, diabetes and kidney disease.

Read our research →

Committed to quality

We accept nothing less than the highest standards of quality and safety. 

Seamlessly integrated

with your existing patient workflows and retinal camera

4,300,000

Increase
Revenue

⬆32%

Average increase in
ancillary revenue
from BioAge

Simple Setup

Get set up online within 24 hours – no technical know-how required. 

Real-time, non-invasive health assessments

Estimates a person’s biological age via vascular and metabolic indicators present in the retinal image, helping them to understand their overall health.

Now available

Performs real-time, non-invasive cardiovascular risk assessments using retinal imagery, along with basic info like age.

Coming soon to USA

  • CLAiR has Breakthrough Device status from the United States Food and Drug Administration (FDA) and is currently undergoing fast-tracked regulatory review.

    CLAiR is expected to be available in United States in 2026, pending FDA clearance.

    Register your interest to be the one of the first to know when it’s available in your region.

These products have varying regulatory statuses depending on region and are not yet cleared for sale in all markets.
Register your interest to learn which products are available in your region.

How BioAge works

1. Capture

Capture images of the retina, along with a few details such as age and sex.

2. Analyse

BioAge™ uses AI and deep learning technology to analyse the retinal images and return results within 30 seconds.

3. Report

Clinicians can view the results in PDF format. Patients receive access to their results via a secure online portal.

How much extra revenue could you be making?

*During a 6-month pilot in California & Texas, optometrists saw a 32% uplift on revenue from ancillary sales.

Calculate the revenue potential of BioAge for your clinic using the calculator below.

Frequently Asked Questions

  • BioAge currently works with the following retinal cameras:

    Topcon: Maestro 1, Maestro 2, NW400, NW500
    Optos: California and Daytona

    Using a different camera model? Register your interest to be notified when BioAge is supported with your hardware.

  • If you’re in a supported region and using one of our approved retinal cameras, you can get started today! After signing up, you’ll receive step-by-step instructions to complete your setup, along with guidance on how to use BioAge and discuss results with your patients. Once setup is complete, we’ll activate your account within 24 hours.

    If your retinal camera isn’t supported yet, we’ll let you know as soon as it is. We’re continuously expanding our compatibility based on demand.

    If you’re located in a region we don’t currently support, we’ll be in touch as soon as we launch there.

  • BioAge is a test that uses AI software technology on images of the retina to estimate a person’s biological age, helping them to understand and take charge of their overall health. See our research to learn more.

  • The BioAge software has no associated risks. As part of the BioAge process, customers will need to have fundus images taken using a retinal camera.

  • BioAge has only been designed for people between the ages of 35-75.

    Currently, BioAge is not designed for individuals who have had a previous cardiac event or with persistent vision impairment, monocular vision, congenital eye disease, history of significant ocular trauma, pathological myopia or those who are pregnant.

  • Patients should be recommended to do an assessment every year.

  • Register your interest to receive an information pack with pricing information.

  • CLAiR has been granted Breakthrough Device status by the U.S. FDA and is currently undergoing fast-tracked regulatory review. It will be made available in the US once approved. We expect this to be some time in 2026.

    Register your interest to be the first to know when it’s available in your region.

  • The BioAge report is not intended to be used for medical decisions or to replace professional medical advice. 

    When someone receives their BioAge results online, they’ll have the option to schedule an appointment with a nearby health and wellbeing partner. 

  • The BioAge result is usually returned within 20-40 seconds of pressing the button.

    The whole BioAge process can add up to three minutes onto appointment times. The BioAge result is usually returned within 20-40 seconds of pressing the button.

    The whole BioAge process can add up to three minutes onto appointment times. 

Adopt the latest Optometry Tech
– Healthcare from the Eye

You’ll receive a no-obligation information pack and an opportunity to secure your spot on the waitlist.